SCHEMBL4185571

SCHEMBL4185571

N#CC(=Cc1ccc(F)c(Cl)c1)S(=O)(=O)Nc1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.55
KMT2A Q03164 3/20 0.55
POLB P06746 2/20 0.55
MAPK1 P28482 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.45
EGFR P00533 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B3 P37058 1/20 0.37
HSD17B2 P37059 1/20 0.37
HSD11B1 P28845 1/20 0.37
PTGES2 Q9H7Z7 2/20 0.36
LMNA P02545 1/20 0.36
IDH1 O75874 1/20 0.36
SOS1 Q07889 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CA2 P00918 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185567 1.00 PKM (0.55) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4185563 1.00 PKM (0.55) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4175095 0.87 PKM (0.52) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4175100 0.87 PKM (0.52) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4175090 0.87 PKM (0.52) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4181400 0.81 PKM (0.46) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4181397 0.81 PKM (0.46) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4181394 0.81 PKM (0.46) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4181650 0.81 PKM (0.37) PKMKMT2APOLBMAPK1L3MBTL1
SCHEMBL4181647 0.81 PKM (0.37) PKMKMT2APOLBMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 PKM 2657/4885KMT2A 469/4885POLB 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.